Fluticasone Propionate Multidose Dry Powder Inhaler and Fluticasone Propionate/Salmeterol in Patients with Asthma

Study Title
Long-Term Safety Study of Fluticasone Propionate (Fp) Multidose Dry Powder Inhaler (MDPI) and Fluticasone Propionate/Salmeterol (FS) MDPI in Patients With Persistent Asthma
Teva Identifier
FSS-AS-305
ClinicalTrials.gov Identifier
NCT02175771
Study Status
Completed
Trial Condition(s)
Persistent Asthma
Interventions
Drug: Fp MDPI | Drug: FS MDPI | Drug: FLOVENT HFA | Drug: ADVAIR DISKUS | Drug: albuterol/salbutamol HFA

Study Description

Please refer to ClinicalTrials.gov for a description of the trial
Print

Click for participation criteria and map of study locations


Key Participation Requirements

Gender
Female, Male
Age Range
12 Years and older
Trial Duration
07/01/2014 - 07/01/2015
Phase
Phase 3

Study Type

Interventional